Description
OTHER FUNCTIONS. IV HOME INFUSION THERAPY - PURCHASE ORDER WITH FUNDING FOR FY12. DECREASE FUNDS BY $23,001.08 TO REMOVE EXCESS FUNDS BEFORE CLOSE OF FY12.
Base award description: IV HOME INFUSION THERAPY - PURCHASE ORDER WITH FUNDING FOR FY12 (NEW FY12 PO TO USE THE CORRECT FUND CONTROL POINT).
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-28+$113,418= $113,418
- Mod P000012012-03-22+$186,583= $300,001
- Mod P000022012-08-06-$23,001= $277,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-28 | +$113,418 | $113,418 | IV HOME INFUSION THERAPY - PURCHASE ORDER WITH FUNDING FOR FY12 (NEW FY12 PO TO USE THE CORRECT FUND CONTROL P… |
| Mod P00001· FUNDING ONLY ACTION | 2012-03-22 | +$186,583 | $300,001 | IV HOME INFUSION THERAPY - PURCHASE ORDER WITH FUNDING FOR FY12. INCREASE FUNDS BY $186,583.08 TO COVER EXPEN… |
| Mod P00002· FUNDING ONLY ACTION | 2012-08-06 | −$23,001 | $277,000 | OTHER FUNCTIONS. IV HOME INFUSION THERAPY - PURCHASE ORDER WITH FUNDING FOR FY12. DECREASE FUNDS BY $23,001.… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SPTKFN23RVE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA24914J0094 | 614-MEMPHIS · Q517 · MEDICAL- PHARMACOLOGY | $240,000 | FY2014 |
| VA24913J5877 | 614-MEMPHIS · Q517 · MEDICAL- PHARMACOLOGY | $189,270 | FY2013 |
| VA24912J0327 | 614-MEMPHIS · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2012 |
| V614C10217 | 614-MEMPHIS · Q517 · MEDICAL- PHARMACOLOGY | $125,241 | FY2011 |
| VA249P0950 | 614-MEMPHIS · Q517 · MEDICAL- PHARMACOLOGY | $0 | FY2011 |
| V614C00349 | 614-MEMPHIS · Q999 · OTHER MEDICAL SERVICES | $126,000 | FY2010 |
Other recipients under Q517 from 614-MEMPHIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24915J3426 | CARDINAL HEALTH 414, LLC | 614-MEMPHIS | $563,502 | FY2015 |
| VA24914J4327 | CARDINAL HEALTH 414, LLC | 614-MEMPHIS | $504,008 | FY2014 |
| VA24913J1688 | CARDINAL HEALTH 414, LLC | 614-MEMPHIS | $177,168 | FY2013 |
| VA24913P1326 | TRIAD ISOTOPES, INC. | 614-MEMPHIS | $43,092 | FY2013 |
| VA24913P1318 | CARDINAL HEALTH 200, LLC | 614-MEMPHIS | $47,478 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24912J1032_3600_VA249P0950_3600 · retrieved 2026-09-26.